Le Tang

2.7k total citations · 3 hit papers
93 papers, 1.6k citations indexed

About

Le Tang is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Le Tang has authored 93 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Molecular Biology, 31 papers in Oncology and 22 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Le Tang's work include Cancer Immunotherapy and Biomarkers (12 papers), Salmonella and Campylobacter epidemiology (11 papers) and Vibrio bacteria research studies (11 papers). Le Tang is often cited by papers focused on Cancer Immunotherapy and Biomarkers (12 papers), Salmonella and Campylobacter epidemiology (11 papers) and Vibrio bacteria research studies (11 papers). Le Tang collaborates with scholars based in China, United States and Canada. Le Tang's co-authors include Guiyuan Li, Can Guo, Wei Xiong, Yong Li, Zhaoyang Zeng, Ming Zhou, Fang Xiong, Bo Xiang, Yingfen Wu and Zhaojian Gong and has published in prestigious journals such as ACS Nano, PLoS ONE and Applied and Environmental Microbiology.

In The Last Decade

Le Tang

84 papers receiving 1.6k citations

Hit Papers

Role of metabolism in cancer cell radioresistance and rad... 2018 2026 2020 2023 2018 2021 2024 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Le Tang China 17 851 562 378 302 238 93 1.6k
Ryouichi Tsunedomi Japan 22 671 0.8× 335 0.6× 610 1.6× 207 0.7× 160 0.7× 64 1.3k
Gaurav S. Choudhary United States 17 1.0k 1.2× 265 0.5× 450 1.2× 250 0.8× 180 0.8× 35 1.7k
Shanrong Liu China 24 1.5k 1.8× 976 1.7× 414 1.1× 205 0.7× 106 0.4× 56 2.1k
Benjamin P. Soule United States 15 558 0.7× 308 0.5× 103 0.3× 378 1.3× 245 1.0× 19 1.3k
Carmine Mancone Italy 25 1.7k 2.0× 851 1.5× 282 0.7× 185 0.6× 81 0.3× 55 2.5k
William Bellamy United States 25 1.7k 2.0× 377 0.7× 969 2.6× 258 0.9× 102 0.4× 54 2.8k
Yasuo Takano Japan 29 1.6k 1.8× 448 0.8× 627 1.7× 370 1.2× 256 1.1× 76 2.6k
Xinying Wang China 24 807 0.9× 421 0.7× 483 1.3× 201 0.7× 162 0.7× 68 1.5k
Eiji Furuta United States 15 1.1k 1.2× 624 1.1× 294 0.8× 128 0.4× 113 0.5× 19 1.5k
Wen Yuan Chung United Kingdom 18 567 0.7× 316 0.6× 289 0.8× 173 0.6× 191 0.8× 60 1.5k

Countries citing papers authored by Le Tang

Since Specialization
Citations

This map shows the geographic impact of Le Tang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Le Tang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Le Tang more than expected).

Fields of papers citing papers by Le Tang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Le Tang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Le Tang. The network helps show where Le Tang may publish in the future.

Co-authorship network of co-authors of Le Tang

This figure shows the co-authorship network connecting the top 25 collaborators of Le Tang. A scholar is included among the top collaborators of Le Tang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Le Tang. Le Tang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Tang, Le, Jiarui Yao, Yiming Zhu, et al.. (2025). Pembrolizumab with Chemotherapy for Patients with Recurrent or Metastatic Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma: A Prospective Phase ll Study. Clinical Cancer Research. 31(9). 1636–1643. 1 indexed citations
4.
Wang, Dan, Yi Zhang, Le Tang, et al.. (2025). circADARB1 enhances ZEB1 expression in an m6A-dependent manner to promote the invasion and migration of nasopharyngeal carcinoma. International Journal of Biological Macromolecules. 318(Pt 4). 145187–145187.
5.
Tang, Le, et al.. (2025). Preclinical advance in nanoliposome-mediated photothermal therapy in liver cancer. Lipids in Health and Disease. 24(1). 31–31. 7 indexed citations
6.
Zhang, Dan, Yue Yang, Haijiao Wang, et al.. (2024). Human umbilical cord mesenchymal stem cells improve uterine incision healing after cesarean delivery in rats by modulating the TGF-β/Smad signaling pathway. Archives of Gynecology and Obstetrics. 310(1). 103–111. 3 indexed citations
7.
Dai, Liyuan, Shasha Wang, Zhishang Zhang, et al.. (2024). A Novel IgG–IgM Autoantibody Panel Enhances Detection of Early-stage Lung Adenocarcinoma from Benign Nodules. Genomics Proteomics & Bioinformatics. 22(6).
8.
Xie, Tongji, et al.. (2024). Artificial neural network systems to predict the response to sintilimab in squamous-cell non-small-cell lung cancer based on data of ORIENT-3 study. Cancer Immunology Immunotherapy. 74(1). 29–29. 1 indexed citations
9.
Chen, Hong, et al.. (2024). Protective Effect of Aloe-emodin on Cognitive Function in Copper-loaded Rats Based on The Inhibition of Hippocampal Neuron Ferroptosis. Current Neurovascular Research. 21(4). 458–471. 2 indexed citations
10.
Lu, Jingyu, et al.. (2024). Proteomic profiling reveals the significance of lipid metabolism in small cell lung cancer recurrence and metastasis. Journal of Translational Medicine. 22(1). 1117–1117. 2 indexed citations
11.
Chen, Mingjian, Yuxin Yang, Guili Ge, et al.. (2023). Biocompatibility and Biological Effects of Surface-Modified Conjugated Polymer Nanoparticles. Molecules. 28(5). 2034–2034. 6 indexed citations
12.
Chen, Cheng, Lin Liu, Yangyang Xu, et al.. (2023). Structural insights of the toxin-antitoxin system VPA0770-VPA0769 in Vibrio parahaemolyticus. International Journal of Biological Macromolecules. 242(Pt 3). 124755–124755. 4 indexed citations
13.
Feng, Yu, Yunxia Tao, Haizhu Chen, et al.. (2023). Efficacy and safety of immune checkpoint inhibitor rechallenge in non‐small cell lung cancer: A systematic review and meta‐analysis. Thoracic Cancer. 14(25). 2536–2547. 15 indexed citations
14.
Zhang, Zhishang, Le Tang, Jiarui Yao, et al.. (2023). High-Throughput Peptide Arrays Identify Potential Diagnostic Autoantibody Signatures in Early-Stage Lung Adenocarcinoma. Cancer Epidemiology Biomarkers & Prevention. 32(5). 726–738. 1 indexed citations
15.
Xu, Chuanming, et al.. (2023). Differential regulation of autophagy on urine-concentrating capability through modulating the renal AQP2 expression and renin-angiotensin system in mice. American Journal of Physiology-Renal Physiology. 325(4). F503–F518. 2 indexed citations
16.
Tang, Le, Dan Shan, Cheng Zhang, et al.. (2021). Enterobacter aerogenes ZDY01 inhibits choline-induced atherosclerosis through CDCA-FXR-FGF15 axis. Food & Function. 12(20). 9932–9946. 20 indexed citations
17.
Jiang, Shiyu, Sheng Yang, Jianliang Yang, et al.. (2019). Evaluating stress, satisfaction and the associated influencing factors of participants in cancer clinical trials: a cross-sectional study in China. BMJ Open. 9(5). e028589–e028589. 1 indexed citations
18.
Wang, Yian, Xiaoling Li, Yongzhen Mo, et al.. (2018). Effects of tumor metabolic microenvironment on regulatory T cells. Molecular Cancer. 17(1). 143 indexed citations
19.
Fang, Wei, Le Tang, Yi He, et al.. (2018). BPIFB1 (LPLUNC1) inhibits radioresistance in nasopharyngeal carcinoma by inhibiting VTN expression. Cell Death and Disease. 9(4). 432–432. 71 indexed citations
20.
Zhu, Songling, Hongliang Wang, Chunxiao Wang, et al.. (2013). Non-contiguous finished genome sequence and description of Salmonella enterica subsp. houtenae str. RKS3027. Standards in Genomic Sciences. 8(2). 198–205. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026